National Multiple Sclerosis Society

EQS-News: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D.

Retrieved on: 
Friday, April 28, 2023
National Center for Complementary and Integrative Health, Sclerosis, Inauguration, Vincent, Cleveland Clinic, Short course immune induction therapy, University, Biogen, Biotechnology, National Center for Research Resources, National Multiple Sclerosis Society, American Academy, Multiple sclerosis, Innovation Unit, Bangladesh Technical Education Board, Cleveland, Advisory Council, Presidential Advisory Council on HIV/AIDS, Council, Neurology, Knowledge, Faculty, Case Western Reserve University School of Medicine, American Academy of Neurology, History of Cleveland Clinic, Holding company, Pharmaceutical industry, Management, Research

Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D.

Key Points: 
  • Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D.
  • Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D.
  • The company also announced that Vincent Ossipow, Ph.D., will step down from the Board, effective June 28, 2023.
  • “We are very grateful to have Rick join us,” stated Duane Nash, M.D., J.D., M.B.A., Chairman of the Board of Directors of Immunic.

Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D.

Retrieved on: 
Thursday, April 27, 2023
National Center for Advancing Translational Sciences, Sclerosis, Inauguration, Vincent, Cleveland Clinic, Short course immune induction therapy, University, Biogen, National Center for Research Resources, National Multiple Sclerosis Society, American Academy, Multiple sclerosis, Innovation Unit, Bangladesh Technical Education Board, Cleveland, Advisory Council, Presidential Advisory Council on HIV/AIDS, Council, Neurology, Knowledge, Faculty, Case Western Reserve University School of Medicine, American Academy of Neurology, History of Cleveland Clinic, Pharmaceutical industry, Management, Research

NEW YORK, April 27, 2023 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced the appointment of Richard Rudick, M.D., a thought-leader in multiple sclerosis with decades of experience in the clinic, academia and industry, to its board of directors, effective April 26, 2023. The company also announced that Vincent Ossipow, Ph.D., will step down from the Board, effective June 28, 2023.

Key Points: 
  • The company also announced that Vincent Ossipow, Ph.D., will step down from the Board, effective June 28, 2023.
  • "We are very grateful to have Rick join us," stated Duane Nash, M.D., J.D., M.B.A., Chairman of the Board of Directors of Immunic.
  • He has published extensively and been an active participant and leader in developing the current treatment landscape for multiple sclerosis.
  • "On behalf of the entire Board of Directors, I would like to thank Vincent for his dedication to Immunic and his thoughtful guidance over the past seven years.

David Weekley Homes Ranks No. 22 on Fortune 100 Best Companies To Work For List

Retrieved on: 
Tuesday, April 4, 2023
The Gate of Heavenly Peace (film), Weekley, National Multiple Sclerosis Society, Big Brothers Big Sisters of America, Big Brothers Big Sisters, Great Places, Positive Coaching Alliance, Publication, Ronald McDonald House Charities, CARE, Sleep

HOUSTON, April 4, 2023 /PRNewswire-PRWeb/ -- Fortune magazine, one of the nation's foremost business publications, has recognized David Weekley Homes as one of the 100 Best Companies to Work For in its annual rankings of employee culture and success.

Key Points: 
  • Fortune magazine, one of the nation's foremost business publications, has recognized David Weekley Homes as one of the 100 Best Companies to Work For in its annual rankings of employee culture and success.
  • HOUSTON, April 4, 2023 /PRNewswire-PRWeb/ -- Fortune magazine, one of the nation's foremost business publications, has recognized David Weekley Homes as one of the 100 Best Companies to Work For in its annual rankings of employee culture and success.
  • "It is an incredible honor to be named for the 17th time on the 100 Best Companies to Work For list," said David Weekley, chairman of David Weekley Homes.
  • 22 on the 100 Best list, which is based on an analysis of anonymous survey responses of more than half a million employees from Great Place To Work Certified™ companies with at least 1,000 workers.

Tom Kuhn to Step Down as EEI President & CEO at the End of 2023

Retrieved on: 
Thursday, March 30, 2023
White House, Yale University, American Society of Association Executives, Edison Electric Institute, United States Energy Association, National Multiple Sclerosis Society, Policy, Nuclear Energy Institute, Electricity, Public policy, MBA, Multimedia, Independent Power Producers Association, Economics, Committee, Organization, Office of Public Liaison, Navy, Member, Spencer Stuart, Alliance to Save Energy, George Washington University, EEI, Society, Safety, Commerce, Son, Management, Ameren

WASHINGTON, March 30, 2023 /PRNewswire/ -- Tom Kuhn today informed the Edison Electric Institute's (EEI's) Board of Directors of his plans to step down as EEI President and CEO after more than 30 years of leading the association that represents all U.S. investor-owned electric companies. Kuhn is EEI's longest-serving president. He will remain in his leadership role through the end of the year, and he plans to stay actively involved in the industry going forward.

Key Points: 
  • "I am incredibly proud of what EEI and our member companies have accomplished together during my tenure.
  • EEI Chair Warner Baxter, executive chairman of Ameren Corporation, said Kuhn's impact on EEI and the electric power industry is immeasurable.
  • Kuhn was elected as EEI President and CEO in 1990.
  • Prior to EEI, Kuhn was president of the American Nuclear Energy Council, which subsequently merged with the Nuclear Energy Institute.

Devic's Syndrome Treatment Global Market Report 2022: Soliris (Eculizumab) to Foster Growth in the Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 22, 2023
Health, Pharmaceutical, Complement component 5, Neuron, Syndrome, C5a, Spinal cord, Neuromyelitis optica spectrum disorder, National Multiple Sclerosis Society, MedImmune, Chugai Pharmaceutical Co., Woman, NMOSD, CNS, Plasma protein binding, Protein, Patient, Immune system, Optic nerve, Alexion, Diagnosis, Rare, Death, Autoantibody, Pharmaceutical industry, Eculizumab

Soliris works by specifically preventing activation of particular proteins in the complement system (C5a and C5b), which play a role in the treatment of Devic s syndrome.

Key Points: 
  • Soliris works by specifically preventing activation of particular proteins in the complement system (C5a and C5b), which play a role in the treatment of Devic s syndrome.
  • Patients suffering with Devic's syndrome possess AQP4 antibody-positive, the body s immune system can turn against itself to produce autoantibodies against AQP4.
  • There are three promising molecules in Devic s syndrome treatment pipeline such as Satralizumab - Phase 3 (Hoffmann-La Roche/ Chugai Pharmaceutical), MEDI-551- Phase 2/3 (MedImmune LLC), and RC18 - Phase 3 (RemeGen, Ltd.).
  • According to National Multiple Sclerosis Society, there are around 4,000 people suffering with Devic's syndrome in the United States with majority of women population.

argenx Announces Planned Transition of Chief Operating Officer

Retrieved on: 
Thursday, March 2, 2023
Autoimmune disease, Myasthenia gravis, National Multiple Sclerosis Society, Pfizer, Research, Roche, Business, University, Neurology, Ophthalmology, Neuroscience, Multiple sclerosis, Business administration, Bachelor of Economics, Marketing, Economics, New product development, Senior, New York University Stern School of Business, Euronext, Master of Business Administration, Infection, Pharmaceutical industry, Management, Genentech

Karen Massey appointed as Chief Operating Officer, effective March 13, 2023

Key Points: 
  • Karen Massey appointed as Chief Operating Officer, effective March 13, 2023
    Amsterdam, the Netherlands — argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karen Massey will join argenx as Chief Operating Officer, effective March 13, 2023.
  • Ms. Massey will succeed Keith Woods, who will remain at argenx for a transition period to support the launch of subcutaneous efgartigimod, after which he will retire and serve as a strategic advisor on the Commercial Committee of the argenx Board of Directors.
  • “Karen brings extensive commercial launch and leadership experience to argenx, specifically within neurology and autoimmune disease.
  • Karen has a genuine passion for innovation and an ability to inspire large, diverse and global teams to deliver results by creating a sense of shared purpose and community,” commented Tim Van Hauwermeiren, Chief Executive Officer at argenx.

Can Mediterranean Diet Help People with MS Preserve Thinking Skills?

Retrieved on: 
Wednesday, March 1, 2023
Exercise, Parkinson's disease, Mount Sinai, Vegetable, Cognition, American Academy of Neurology, Disease, MS, Body mass index, Thought, Icahn School of Medicine at Mount Sinai, DSM-IV codes, Eating, Epilepsy, Multiple sclerosis, Cognitive deficit, Risk, Smoking, Brain, National Multiple Sclerosis Society, Social media, Concussion, Stroke, Olive oil, Nervous system, Migraine, American Academy, Annual general meeting, Deficit spending, Memory, Alzheimer's disease, Research, Diet, Bangladesh Technical Education Board, AAN, Irma, Salt, Dietary supplement, Design, Medical imaging, Pharmaceutical industry, MD, Neurology

"Cognitive difficulties are very common in MS, and they often get worse over time, even with treatment with disease-modifying therapies.

Key Points: 
  • "Cognitive difficulties are very common in MS, and they often get worse over time, even with treatment with disease-modifying therapies.
  • People living with MS are very interested in ways they can be proactive from a lifestyle perspective to help improve their outcomes."
  • The study involved 563 people with MS. People completed a questionnaire to show how closely they followed the Mediterranean diet.
  • The researchers found that people who more closely followed the Mediterranean diet had a 20% lower risk for cognitive impairment than people who did not follow the diet.

Wealth Management Team Led by Eric Yamin and Keith Caparelli Joins First Republic

Retrieved on: 
Monday, January 9, 2023
Banking, Asset Management, Professional Services, Finance, Holy Cross School, UCLA, UBS, Oppenheimer, Trust, Tufts University, Insurance, National Multiple Sclerosis Society, National Capital Chapter, Family, First Republic Bank, Morgan Stanley, Jonathan Caparelli, FINANCIAL, NYSE, Republic Bank, Fordham University, Strategic management, Woman, Wealth, National Multiple Sclerosis Society, Concourse House, Wharton School of the University of Pennsylvania, FRC, School, Financial services, Management, Celebration, First Republic, Northwestern

First Republic Bank (NYSE:FRC), a leading private bank and wealth management company, today announced that a four-person team led by Eric Yamin and Keith Caparelli has joined First Republic Investment Management.

Key Points: 
  • First Republic Bank (NYSE:FRC), a leading private bank and wealth management company, today announced that a four-person team led by Eric Yamin and Keith Caparelli has joined First Republic Investment Management.
  • Based in Florida and New York, the team will provide portfolio management, retirement planning, investment consulting and other wealth management services to individuals, families, nonprofits and private family foundations.
  • “Eric Yamin, Keith Caparelli and their team will further strengthen First Republic’s ability to serve clients in Florida and New York,” said Bob Thornton, President of First Republic Private Wealth Management.
  • Founded in 1985, First Republic and its subsidiaries offer private banking, private business banking and private wealth management.

Verana Health Developing Qdata MS, a Real-World Data, Curated Neurology Research Module for Multiple Sclerosis

Retrieved on: 
Wednesday, November 16, 2022
Quality of life, SAN, Doctor of Philosophy, American Academy of Neurology, HCP, EHR, National Multiple Sclerosis Society, Classification, MD, American Academy of Ophthalmology, Health, Woman, Population, Parkinson's disease, Solution, MS, RWD, Physician, Data management, Man, Medicine, Spinal cord, Data, Phenotype, ICDS, Multiple sclerosis, EDSS, Intelligence, Research, NMOSD, Patient, Stanford University, CEO, RWE, American Urological Association, Central nervous system, HCPS, Immune system, Brain, CNS, Diagnosis, American Academy, Disease, SMA, Pharmaceutical industry, Medical imaging, Ophthalmology, Neurology

SAN FRANCISCO, Nov. 16, 2022 /PRNewswire/ -- Verana Health a digital health company elevating quality in real-world data (RWD)today announced it is developing Qdata MS , a Neurology Qdata module that will be used to help advance clinical research and develop therapeutic strategies for treating patients with multiple sclerosis (MS).

Key Points: 
  • SAN FRANCISCO, Nov. 16, 2022 /PRNewswire/ -- Verana Health a digital health company elevating quality in real-world data (RWD)today announced it is developing Qdata MS , a Neurology Qdata module that will be used to help advance clinical research and develop therapeutic strategies for treating patients with multiple sclerosis (MS).
  • The Axon Registry, managed by Verana Health's VeraQ population health data engine, is one of the largestand growingreal-world clinical data registries for neurology.
  • As the Qdata MS module evolves through development, it is estimated to include de-identified, curated RWD from about 30,000 patients diagnosed with MS, one of the largest longitudinal multiple sclerosis datasets for research use.
  • Using its clinician-informed and artificial intelligence-enhanced VeraQpopulation health data engine, Verana Health transforms structured and unstructured healthcare data into curated, disease-specific data modules, Qdata.

Sollis Health Announces New Chief Executive Officer

Retrieved on: 
Wednesday, September 14, 2022
Health, General Health, Radiology, Research, Science, Pharmaceutical, Biotechnology, Harvard College, Olson, National Multiple Sclerosis Society, Director, LLC, Â, Company, Starwood, Harvard Business School, Social media, DEI, Physician, CEO, Greater, SPG, Board of directors, Board, Medicine, Multimedia, Health, Michael Sollis, Concierge medicine, Radiology, Bain, Management, The Hamptons

Sollis Health , the 24/7 members-only concierge medical service, has named Brad Olson as Chief Executive Officer effective September 19, 2022.

Key Points: 
  • Sollis Health , the 24/7 members-only concierge medical service, has named Brad Olson as Chief Executive Officer effective September 19, 2022.
  • Prior to joining Sollis, Olson served as Chief Business Officer at Peloton, where he oversaw the companys subscription business including consumer engagement and retention as well as new business development and digital distribution.
  • I am incredibly excited to join the Sollis Health team and lead the company into a new chapter, said Olson.
  • Sollis Health is a 24/7 doctor, emergency room, and concierge service rolled into one.